GenScript Biotech

Genscript Biotech Corporation is a global biotech company. The Company’s mission is to “Make the Human and Nature Healthier through Biotechnology”. Genscript Biotech Corporation is a leading life sciences research and application service and product provider that applies its proprietary technology to various fields from basic life sciences research to translational biomedical development, industrial synthetic products, and cell therapeutic solutions. Leveraging in the Group’s proprietary gene synthesis and other technology and know-hows, the Group has established four major platforms including (i) a leading contracted research organization (“CRO”) platform to provide one-stop solutions to global research communities; (ii) a contract development and manufacturing organization (“CDMO”) platform; (iii) an industrial synthetic products platform; and (iv) an integrated global cell therapy platform. The CRO platform remains as the strong and stable revenue generating foundation for the entire corporate. The CDMO platform provides end-to-end biologics discovery and development services to pharmaceutical, biotech, government and academic customers worldwide. The industrial synthetic products platform develops products for food and feed processing and other industrial uses. The cell therapy platform provides cell therapy solutions to patients with refractory diseases including cancer and inflammatory diseases. Backed by gene synthesis and editing technology, the Group has made significant progress in its synthetic biology research and application, which mainly materialized into its innovative chimeric antigen receptor (“CAR”) T-cell (“CAR-T”) therapy and industrial enzyme businesses. With a strong sales and marketing team and strong research and development capabilities, the Company maintains a stable and sustainable growth.

Lab Information

GenScript Biotech

Research Area and Skills

Recognize this scientist’s Expertise for their contribution in your research

Cell therapy 1 Immuno-oncology 1 Immunology 1 Molecular Biology 0 Oligo 0 Protein 0 Peptide 0

More

  • Post
  • Publication
  • Plasmid
  • Following (4)
  • Follower (4)

The value of mRNA therapeutics has come into the general public’s attention by the rapid authorization and approval of high-efficacy mRNA vaccines (i.e., Moderna and Pfizer) for COVID-19. The seemingly whirlwind events leading to this new vaccine modality have created a ...Learn More


Evolution of DNA sequencingDNA sequencing is the process of identifying the exact order of nucleotide bases (i.e., Adenine, Cytosine, Guanine, and Thymine) encoding specific genomic information. DNA sequencing technology rapidly advanced from its inception in the 1970s with the ...Learn More


Neoantigen Peptides in Personalized T Cell Immunotherapies for MedulloblastomaWhat is medulloblastoma?Medulloblastoma is a common malignant brain tumor in children, in fact, the most frequently diagnosed, accounting for over 60% of intracranial embryonal tumors. First described ...Learn More


Evolution of DNA sequencingDNA sequencing is the process of identifying the exact order of nucleotide bases (i.e., Adenine, Cytosine, Guanine, and Thymine) encoding specific genomic information. DNA sequencing technology rapidly advanced from its inception in the 1970s with the ...Learn More


Using CRISPR and Non Viral DNA in T-Cell Engineering



This guy hasn’t publications anything yet.

Cloud Scientists

About Us · User Accounts and Benefits · Privacy Policy · Management Center · FAQs
© 2022 MolecularCloud